Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols
Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and Stage IV B-cell non-Hodgkin's lymphoma (B-NHL) results of the UKCCSG 9003 protocol
Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: A study of the French Society of Pediatric Oncology
High survival rate in advanced stage B cell lymphoma and leukaemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomised trial of 216 children
Outcome of relapsed childhood B-cell lymphoma (BCL) after intensive first line treatment (Tt): The experience of the French Society of Pediatric Oncology (SFOP) in the LMB89 protocol
Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: A report from the Societe Francaise de Oncologie Pediatrique
Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified from biological subtypes and stage - A report of the Berlin-Frankfurt-Munster Group